温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.fr.com/insights/ip-law-essentials/orange-book-101
点击访问原文链接

Orange Book 101 | The FDA's Official Register of Drugs

进入原网站 导航首页
Why FishDiversity, Equity & InclusionPro Bono & Social ResponsibilityLegal OperationsPricingLegal Project ManagementKnowledge ManagementeDiscoveryLegal Technology ServicesOur PeopleServicesLitigationPatent LitigationTrademark, Copyright & Media LitigationTrade Secret LitigationAppellateITC Litigation & Section 337Standard Essential PatentsChancery & Corporate GovernancePost-GrantInter Partes ReviewPost-Grant ReviewEx Parte ReexaminationSupplemental ExaminationPatentPatent ProsecutionStrategic Patent Counseling & OpinionsPatent Portfolio ManagementUnitary Patent & Unified Patent CourtIP Licensing, Transactions & AgreementsTrademark & Copyright Counseling & ProsecutionStrategic Counseling, Registration & OpinionsAdvertising & MarketingDomain Names & InternetTTAB Oppositions & CancellationsDigital Millennium Copyright ActTransactions & AgreementsRegulatory & Government AffairsCommunications & Spectrum RegulationDrug & Medical Device RegulationmHealth & TelemedicinePrivacy & Data SecurityIndustriesElectrical & Computer TechnologySoftware & InternetHardwareSemiconductorsConsumer ElectronicsOpticsArtificial IntelligenceDigital HealthDigital Media & E-CommerceFinancial, Business & FinTech ServicesTelecommunicationsEnergy & ChemicalsPetrochemicalCleantechLife SciencesBiotech & DiagnosticsMedical DevicesPharmaceuticalsAcademic Research & Medical CentersTransportation, Aerospace & DefenseManufacturingAutonomous VehiclesInsightsThought LeadershipIP Law EssentialsPost-Grant Annual ReportsWebinarsPodcastsOfficesCareersNews & EventsContact UsHomeInsightsIP Law EssentialsKelly Allenspach Del DottoherehereDrug & Medical Device RegulationLitigationPatent LitigationRegulatory & Government AffairsLife SciencesPharmaceuticalsBlog January 30, 2026 D. Mass.: “Ensnarement” — a Potent but Often Overlooked Defense to the Doctrine of Equivalents — Need Not Be Raised in the Pleadings Read moreBlog December 30, 2025 Court Declines To Lift 30-Month Stay To Prevent Alleged Unfair Competitive Advantage Between Generics  Read moreBlog October 16, 2025 District of Delaware Finds Use of Antibody Tech Protected by Safe Harbor Read moreBlog October 3, 2025 District of Delaware Considers Scope of Injunction in Jazz v. Avadel Remand Read moreBlog June 5, 2025 Federal Circuit Reverses Injunction That Barred Clinical Trials in Jazz v. Avadel Read moreBlog March 3, 2025 Recent Decisions and FTC Challenges Dictate Caution When Listing Patents in the Orange Book Read moreBlog January 15, 2025 The Not-So-Safe Harbor for Research Tools: Lessons From the District of Delaware Read moreArticle September 16, 2024 Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies Read moreBlog September 5, 2024 The Final Word on an Alleged Infringer’s Intent in a Hatch-Waxman Safe Harbor Analysis Read moreBlog May 9, 2024 Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis Read moreBlog April 29, 2026 SCOTUS Narrows Secondary Liability Under Copyright Read moreArticle April 27, 2026 The Cost of Inaction as Standardization Comes for the EV and Battery Industries Read moreBlog April 23, 2026 Dot or Not: Federal Circuit Agrees a Dot Can Prevent Confusion Read moreBlog April 15, 2026 USPTO, DOJ Statement of Interest Supports Injunctive Relief   Read moreBlog March 24, 2026 Federal Circuit Denies All Mandamus Petitions Challenging Discretionary Denial Policies Read moreBlog March 17, 2026 The Federal Circuit Continues to Evolve Its Daubert Gatekeeping Framework: Willis and Exafer Read moreBlog March 9, 2026 Biologics and Biosimilars Landscape 2025: IP, Policy, and Market Developments Read moreBlog February 24, 2026 The Shifting SEP Litigation Landscape: How Changes in the Types of Litigated SEPs Can Affect Implementers Read moreBlog February 19, 2026 Be Careful What You Wish For: How Stipulations Become Federal Circuit Issues Read moreArticle February 13, 2026 Semiconductor Litigation: Advanced Process Transitions and the Next Wave of Patent Risk Read moreOfficesAtlantaAustinBostonChicagoDallasDelawareHoustonMinneapolisMunichNew YorkOrange CountySan DiegoShenzhenSilicon ValleyWashington, D.C.CareersLife at FishJudicial ClerksLaw StudentsLateral HiresScientists & EngineersOperations & Admin StaffTraining & BenefitsFAQSubscribeContact UsSite MapCookie PolicyDisclaimerPrivacy PolicyTerms of Use

智能索引记录